Please login to the form below

Not currently logged in
Email:
Password:

Two MDs leave CCC

Carsten Edwards, MD of Brandtectonics Access, and Vicky Hunt, MD of Allidura, are leaving Chandler Chicco Companies

Carsten Edwards, MD of Brandtectonics Access, and Vicky Hunt, MD of Allidura, are leaving Chandler Chicco Companies (CCC).

It is believed that Edwards will be moving to Ogilvy Healthworld at the end his three-month notice period. He joined CCC in 2008, first as director at Brandtectonics, and he was promoted to MD in April 2010. Prior to this, Edwards was at Bristol-Myers Squibb.

Vicky Hunt is leaving CCC after 10 years to move out of London and spend more time with her family. While at CCC she worked in three of its business units, leading two of them for periods.

Fiona Hall, EU MD at CCC said: "We are very sad to see Vicky leave but wish her the very best and hope she really enjoys spending more time with her children. We also thank Carsten and wish him well for the future."

A new MD for Allidura will be "announced in due course." It is unclear whether Edwards would be replaced.

Brandtectonics Access underwent a restructure in December 2010 when it was split across a number of CCC businesses following an annual review.

Hall said: "We review our business on an annual basis to consider how we can evolve to best service the needs of our clients moving forward. It became clear to us that our clients' growing market access needs would be best served by integrating our offer across the CCC business units so that market access counsel would be readily available and integrated."

CCC has said it will be looking at how to move Brandtectonics forward in light of these recent changes.

12th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics